P Gaynor

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. doi request reprint Comparison of safety outcomes among Caucasian, Hispanic, Black, and Asian patients in duloxetine studies of chronic painful conditions
    Paula J Gaynor
    Lilly USA, LLC, Indianapolis, IN 46285, USA
    Curr Med Res Opin 29:549-60. 2013
  2. pmc Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial
    Lesley M Arnold
    Women s Health Research Program, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 222 Piedmont Avenue, Suite 8200, Cincinnati, OH 45219, USA
    Arthritis Res Ther 13:R86. 2011
  3. doi request reprint Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies
    P Gaynor
    United States Medical Division, Lilly USA, LLC, Indianapolis, IN 46285, USA
    Int J Clin Pract 65:341-9. 2011
  4. doi request reprint Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study
    Paula J Gaynor
    Eli Lilly and Company, Indianapolis, IN, USA
    Curr Med Res Opin 27:1859-67. 2011
  5. doi request reprint A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms
    Paula J Gaynor
    Eli Lilly and Company, Indianapolis, IN, USA
    Curr Med Res Opin 27:1849-58. 2011

Collaborators

Detail Information

Publications5

  1. doi request reprint Comparison of safety outcomes among Caucasian, Hispanic, Black, and Asian patients in duloxetine studies of chronic painful conditions
    Paula J Gaynor
    Lilly USA, LLC, Indianapolis, IN 46285, USA
    Curr Med Res Opin 29:549-60. 2013
    ..This post-hoc analysis was conducted to investigate if safety outcomes differed among race/ethnic subgroups of patients treated with duloxetine for chronic painful conditions...
  2. pmc Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial
    Lesley M Arnold
    Women s Health Research Program, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 222 Piedmont Avenue, Suite 8200, Cincinnati, OH 45219, USA
    Arthritis Res Ther 13:R86. 2011
    ..Fatigue was assessed as a secondary objective in a 2-phase, 24-week study in outpatients with American College of Rheumatology-defined fibromyalgia...
  3. doi request reprint Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies
    P Gaynor
    United States Medical Division, Lilly USA, LLC, Indianapolis, IN 46285, USA
    Int J Clin Pract 65:341-9. 2011
    ....
  4. doi request reprint Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study
    Paula J Gaynor
    Eli Lilly and Company, Indianapolis, IN, USA
    Curr Med Res Opin 27:1859-67. 2011
    ..Duloxetine has demonstrated efficacy in treating MDD and other certain painful conditions; this study specifically evaluated patients with both MDD and MDD-associated pain...
  5. doi request reprint A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms
    Paula J Gaynor
    Eli Lilly and Company, Indianapolis, IN, USA
    Curr Med Res Opin 27:1849-58. 2011
    ..Duloxetine has demonstrated efficacy in treating both MDD and certain other painful conditions. This randomized, double-blind clinical trial assessed the effects of duloxetine in patients with both MDD and MDD-associated physical pain...